These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 31939429)
81. Microwave ablation of hepatic tumors with a third generation system: loco‑regional efficacy in a prospective cohort study with intermediate term follow-up. Meloni MF; Galimberti S; Dietrich CF; Lazzaroni S; Goldberg SN; Abate A; Sironi S; Andreano A Z Gastroenterol; 2016 Jun; 54(6):541-7. PubMed ID: 27284928 [TBL] [Abstract][Full Text] [Related]
82. Detectability of liver metastases in malignant melanoma: prospective comparison of magnetic resonance imaging and positron emission tomography. Ghanem N; Altehoefer C; Högerle S; Nitzsche E; Lohrmann C; Schäfer O; Kotter E; Langer M Eur J Radiol; 2005 May; 54(2):264-70. PubMed ID: 15837408 [TBL] [Abstract][Full Text] [Related]
83. Evaluation of the MR and pathology characteristics immediately following percutaneous MR-guided microwave ablation in a rabbit kidney VX2 tumor implantation model. Li H; Lin Z; Chen J; Guo R Int J Hyperthermia; 2019; 36(1):1197-1206. PubMed ID: 31814458 [No Abstract] [Full Text] [Related]
85. The Liverpool uveal melanoma liver metastases pathway: outcome following liver resection. Gomez D; Wetherill C; Cheong J; Jones L; Marshall E; Damato B; Coupland SE; Ghaneh P; Poston GJ; Malik HZ; Fenwick SW J Surg Oncol; 2014 May; 109(6):542-7. PubMed ID: 24357463 [TBL] [Abstract][Full Text] [Related]
86. Computed tomography-guided microwave ablation of perivascular liver metastases from colorectal cancer: a study of the ablation zone, feasibility, and safety. Izaaryene J; Drai M; Deniel C; Bridge P; Rico G; Daidj N; Gilabert M; Ewald J; Turrini O; Piana G Int J Hyperthermia; 2021; 38(1):887-899. PubMed ID: 34085891 [TBL] [Abstract][Full Text] [Related]
87. Microwave ablation assisted by three-dimensional visualization system as local therapy for relapsed hepatoblastoma: a small pilot study. Cui R; Yu J; Gu Y; Cao F; Liu FY; Dong LN; Liang P Abdom Radiol (NY); 2019 Aug; 44(8):2909-2915. PubMed ID: 31089779 [TBL] [Abstract][Full Text] [Related]
88. Microwave ablation for hepatocellular carcinoma associated with Budd-Chiari syndrome after transarterial chemoembolization: an analysis of ten cases. Dou JP; Yu J; Han ZY; Liu FY; Cheng ZG; Liang P Abdom Radiol (NY); 2017 Mar; 42(3):962-968. PubMed ID: 27688061 [TBL] [Abstract][Full Text] [Related]
90. Contrast-enhanced ultrasound in the characterization of hepatocellular carcinomas treated by ablation: comparison with contrast-enhanced magnetic resonance imaging. Qu P; Yu X; Liang P; Cheng Z; Han Z; Liu F; Yu J Ultrasound Med Biol; 2013 Sep; 39(9):1571-9. PubMed ID: 23830098 [TBL] [Abstract][Full Text] [Related]
91. Higher Efficiency of Percutaneous Microwave (MWA) Than Radiofrequency Ablation (RFA) in Achieving Complete Response in Cirrhotic Patients with Early Hepatocellular Carcinoma. Gaia S; Ciruolo M; Ribaldone DG; Rolle E; Migliore E; Mosso E; Vola S; Risso A; Fagoonee S; Saracco GM; Carucci P Curr Oncol; 2021 Feb; 28(2):1034-1044. PubMed ID: 33669107 [TBL] [Abstract][Full Text] [Related]
92. Safety assessment and therapeutic efficacy of percutaneous microwave ablation therapy combined with percutaneous ethanol injection for hepatocellular carcinoma adjacent to the gallbladder. Huang H; Liang P; Yu XL; Cheng ZG; Han ZY; Yu J; Liu FY Int J Hyperthermia; 2015 Feb; 31(1):40-7. PubMed ID: 25766386 [TBL] [Abstract][Full Text] [Related]